Deficit accumulation frailty index and treatment tolerability in AML: Data from CALGB 11001 and 11002 (Alliance)

Authors

Catherine Lai, University of Pennsylvania
Minji Lee, Mayo Clinic
Olivia Bobek, Mayo Clinic
Jennifer Le-Rademacher, Mayo Clinic
Sumithra Mandrekar, Mayo Clinic
Gail J Roboz, Weill Cornell Medical College
Geoffrey L Uy, Washington University School of Medicine in St. Louis
Jeanne S Mandelblatt, Georgetown University
Heidi D Klepin, Wake Forest University

Journal

Blood Advances

Publication Date

1-28-2025

Volume

9

Issue

2

First Page

398

Last Page

401

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2024014367

Rights and Permissions

Lai C, Lee M, Bobek O, Le-Rademacher J, Mandrekar S, Roboz GJ, Uy GL, Mandelblatt JS, Klepin HD. Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance). Blood Adv. 2025 Jan 28;9(2):398-401. doi: 10.1182/bloodadvances.2024014367. © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Lai, Catherine; Lee, Minji; Bobek, Olivia; Le-Rademacher, Jennifer; Mandrekar, Sumithra; Roboz, Gail J; Uy, Geoffrey L; Mandelblatt, Jeanne S; and Klepin, Heidi D, "Deficit accumulation frailty index and treatment tolerability in AML: Data from CALGB 11001 and 11002 (Alliance)." Blood Advances. 9, 2. 398 - 401. (2025).
https://digitalcommons.wustl.edu/oa_4/4856

Department

ICTS (Institute of Clinical and Translational Sciences)